Singapore markets closed

Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.260.00 (0.00%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.74B
Enterprise value 3.06B
Trailing P/E 22.76
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.22
Price/book (mrq)1.69
Enterprise value/revenue 2.47
Enterprise value/EBITDA 20.95

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-24.57%
S&P500 52-week change 322.55%
52-week high 329.80
52-week low 317.65
50-day moving average 322.83
200-day moving average 324.11

Share statistics

Avg vol (3-month) 3581.45k
Avg vol (10-day) 3567.98k
Shares outstanding 5135.44M
Implied shares outstanding 6135.44M
Float 854.37M
% held by insiders 162.40%
% held by institutions 14.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 41.48%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 31.48%
5-year average dividend yield 41.26
Payout ratio 431.46%
Dividend date 3N/A
Ex-dividend date 413 Jun 2024
Last split factor 21.4:1
Last split date 327 May 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.72%
Operating margin (ttm)13.12%

Management effectiveness

Return on assets (ttm)3.88%
Return on equity (ttm)7.43%

Income statement

Revenue (ttm)1.24B
Revenue per share (ttm)9.14
Quarterly revenue growth (yoy)33.80%
Gross profit (ttm)N/A
EBITDA 208.49M
Net income avi to common (ttm)120.49M
Diluted EPS (ttm)0.89
Quarterly earnings growth (yoy)31.50%

Balance sheet

Total cash (mrq)148.14M
Total cash per share (mrq)1.09
Total debt (mrq)462.51M
Total debt/equity (mrq)28.42%
Current ratio (mrq)1.17
Book value per share (mrq)11.96

Cash flow statement

Operating cash flow (ttm)162.26M
Levered free cash flow (ttm)19.37M